State of Wyoming’s Novartis NVS Stock Holding History

State of Wyoming’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Sell	792 -150	-16%	-$22.5K	0.01%	1310
2026 Q1	$144K	Sell	942 -60	-6%	-$9.2K	0.02%	1125
2025 Q4	$138K	Sell	1,002 -50	-5%	-$6.55K	0.02%	1172
2025 Q3	$135K	Sell	1,052 -50	-5%	-$6.1K	0.02%	1169
2025 Q2	$133K	Sell	1,102 -18	-2%	-$2.03K	0.02%	1156
2025 Q1	$125K	Sell	1,120 -10	-0.9%	-$1.06K	0.02%	1051
2024 Q4	$110K	Hold	1,130	–	–	0.01%	1131
2024 Q3	$130K	Buy	1,130 +520	+85%	+$59K	0.02%	969
2024 Q2	$64.9K	Buy	610 +10	+2%	+$1K	0.01%	1246
2024 Q1	$58K	Buy	+600	New	+$61.5K	0.01%	1256

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State of Wyoming's NVS Position: Q2 2026 in Review

State of Wyoming reduced its Novartis (NVS) stake by 16% in Q2 2026, selling an estimated $22.5K and leaving 792 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #1310.

State of Wyoming first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $144K in Q1 2026. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

State of Wyoming held 792 shares of Novartis worth $124K as of Q2 2026.
State of Wyoming sold 150 Novartis shares in Q2 2026, an estimated $22.5K.
Novartis made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1310 holding.
State of Wyoming first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
State of Wyoming's Novartis position peaked at $144K in Q1 2026.
1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.